PL449564A1 - Macroporous bone implant based on calcium-magnesium zeolite CaMg-Xs functionalized with chitosan and method of its production - Google Patents

Macroporous bone implant based on calcium-magnesium zeolite CaMg-Xs functionalized with chitosan and method of its production

Info

Publication number
PL449564A1
PL449564A1 PL449564A PL44956424A PL449564A1 PL 449564 A1 PL449564 A1 PL 449564A1 PL 449564 A PL449564 A PL 449564A PL 44956424 A PL44956424 A PL 44956424A PL 449564 A1 PL449564 A1 PL 449564A1
Authority
PL
Poland
Prior art keywords
chitosan
camg
nanopowder
powder
bone implant
Prior art date
Application number
PL449564A
Other languages
Polish (pl)
Inventor
Agata Przekora-Kuśmierz
Paulina Kazimierczak
Alicja Wójcik
Wojciech Franus
Jakub Matusiak
Rafał Panek
Original Assignee
Uniwersytet Medyczny W Lublinie
Politechnika Lubelska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Medyczny W Lublinie, Politechnika Lubelska filed Critical Uniwersytet Medyczny W Lublinie
Priority to PL449564A priority Critical patent/PL449564A1/en
Publication of PL449564A1 publication Critical patent/PL449564A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/12Phosphorus-containing materials, e.g. apatite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/20Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3645Connective tissue
    • A61L27/365Bones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/42Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56Porous materials, e.g. foams or sponges

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Materials For Medical Uses (AREA)

Abstract

Przedmiotem zgłoszenia jest makroporowaty implant kostny, który charakteryzuje się tym, że stanowi go chitozan, agaroza, hydroksyapatyt w postaci proszku lub nanoproszku oraz zeolit CaMg-X sfunkcjonalizowanego za pomocą chitozanu (CaMg-X-chitozan) w postaci proszku lub nanoproszku, rozprowadzone w 2% (v/v) wodnym roztworze kwasu octowego, przy czym proporcje wagowe stałych komponentów wynoszą odpowiednio 2% (w/v) chitozanu, 5% (w/v) agarozy, 20% (w/v) hydroksyapatytu w postaci proszku lub nanoproszku oraz 20% (w/v) zeolitu CaMg-X-chitozan w postaci proszku lub nanoproszku w odniesieniu do kwasu octowego. Zgłoszenie obejmuje także sposób wytwarzania implantu kostnego według wynalazku, który polega na tym, że agarozę, hydroksyapatyt w postaci proszku lub nanoproszku oraz zeolit CaMg-X sfunkcjonalizowany za pomocą chitozanu (CaMg-X-chitozan) w postaci proszku lub nanoproszku rozprowadza się w roztworze chitozanu przygotowanym w kwasie octowym. Następnie do jednolitej masy dodaje się wodorowęglan sodu (NaHCO3) jako porogen. Otrzymany rodzaj pasty poddaje się działaniu wysokiej temperatury, a następnie zamrożeniu oraz procesowi liofilizacji. Po liofilizacji, otrzymany biomateriał namacza się w buforowanym roztworze soli fizjologicznej (PBS) i suszy na powietrzu. Otrzymany według wynalazku implant kostny charakteryzuje się wysokoporowatą mikrostrukturą, jest nietoksyczny oraz sprzyja adhezji i proliferacji osteoblastów na jego powierzchni. Otrzymany według wynalazku biomateriał może znaleźć zastosowanie jako implant kostny do leczenia złamań kości o różnej etiologii, gdzie będzie wspierał adhezję osteoblastów (komórek kościotwórczych) i ich aktywność kościotwórczą, a tym samym proces osseointegracji.The subject of the application is a macroporous bone implant, which is characterized in that it consists of chitosan, agarose, hydroxyapatite in the form of powder or nanopowder and CaMg-X zeolite functionalized with chitosan (CaMg-X-chitosan) in the form of powder or nanopowder, distributed in a 2% (v/v) aqueous solution of acetic acid, wherein the weight proportions of the solid components are 2% (w/v) chitosan, 5% (w/v) agarose, 20% (w/v) hydroxyapatite in the form of powder or nanopowder and 20% (w/v) CaMg-X-chitosan zeolite in the form of powder or nanopowder in relation to acetic acid, respectively. The application also includes a method of producing a bone implant according to the invention, which consists in distributing agarose, hydroxyapatite in the form of powder or nanopowder and CaMg-X zeolite functionalized with chitosan (CaMg-X-chitosan) in the form of powder or nanopowder in a chitosan solution prepared in acetic acid. Then, sodium bicarbonate (NaHCO3) is added to the homogeneous mass as a porogen. The obtained type of paste is subjected to high temperature, then freezing and the lyophilization process. After lyophilization, the obtained biomaterial is soaked in a buffered physiological saline solution (PBS) and air-dried. The bone implant obtained according to the invention is characterized by a highly porous microstructure, is non-toxic and promotes the adhesion and proliferation of osteoblasts on its surface. The biomaterial obtained according to the invention can be used as a bone implant for the treatment of bone fractures of various etiologies, where it will support the adhesion of osteoblasts (bone-forming cells) and their bone-forming activity, and thus the osseointegration process.

PL449564A 2024-08-22 2024-08-22 Macroporous bone implant based on calcium-magnesium zeolite CaMg-Xs functionalized with chitosan and method of its production PL449564A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL449564A PL449564A1 (en) 2024-08-22 2024-08-22 Macroporous bone implant based on calcium-magnesium zeolite CaMg-Xs functionalized with chitosan and method of its production

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL449564A PL449564A1 (en) 2024-08-22 2024-08-22 Macroporous bone implant based on calcium-magnesium zeolite CaMg-Xs functionalized with chitosan and method of its production

Publications (1)

Publication Number Publication Date
PL449564A1 true PL449564A1 (en) 2025-04-22

Family

ID=95451071

Family Applications (1)

Application Number Title Priority Date Filing Date
PL449564A PL449564A1 (en) 2024-08-22 2024-08-22 Macroporous bone implant based on calcium-magnesium zeolite CaMg-Xs functionalized with chitosan and method of its production

Country Status (1)

Country Link
PL (1) PL449564A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL235822B1 (en) * 2018-08-24 2020-11-02 Univ Medyczny W Lublinie Cryogel bone scaffold based on chitosan and calcium phosphate bioceramics as well as method of producing it
PL242079B1 (en) * 2020-10-29 2023-01-16 Politechnika Poznańska Titanium material for an implant and method for its production

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL235822B1 (en) * 2018-08-24 2020-11-02 Univ Medyczny W Lublinie Cryogel bone scaffold based on chitosan and calcium phosphate bioceramics as well as method of producing it
PL242079B1 (en) * 2020-10-29 2023-01-16 Politechnika Poznańska Titanium material for an implant and method for its production

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
NIH; Yue Li et al. "Zeolites: A series of promising biomaterials in bone tissue engineering" Front. Bioeng. Biotechnol., 17 November 2022, Sec. Biomaterials, Volume 10 - 2022 | https://doi.org/10.3389/fbioe.2022.1066552 *
ScienceDirect; M. Sandomierski et al."Chitosan - zeolite scaffold as a potential biomaterial in the controlled release of drugs for osteoporosis", International Journal of Biological Macromolecules, Volume 223, Part A, 31 December 2022, Pages 812-820 *
tandfonline.com; M. Saheban et al."Effect of zeolite on the corrosion behavior, biocompatibility and antibacterial activity of porous magnesium/zeolite composite scaffolds", Materials Technology Advanced Performance Materials, Volume 34, 2019 - Issue 5, https://doi.org/10.1080/10667857.2018.1549803 *

Similar Documents

Publication Publication Date Title
Wang et al. Synthesis and characterization of hierarchically macroporous and mesoporous CaO–MO–SiO2–P2O5 (M= Mg, Zn, Sr) bioactive glass scaffolds
JP5882997B2 (en) Bone graft system
HRP20180030T1 (en) BIODEGRADABLE COMPOSITE MATERIAL
WO2008096334A3 (en) A collagen/hydroxyapatite composite scaffold, and process for the production thereof
WO2017219654A1 (en) Degradable, porous, magnesium-containing calcium phosphate-calcium sulfate composite biological stent
WO2016012583A1 (en) Printable morphogenetic phase-specific chitosan-calcium-polyphosphate scaffold for bone repair
Hayashi et al. Honeycomb scaffolds fabricated using extrusion molding and the sphere-packing theory for bone regeneration
US8936638B2 (en) Coral bone graft substitute
PL426788A1 (en) Cryogel bone scaffold based on chitosan and calcium phosphate bioceramics as well as method of producing it
RU2015106808A (en) HYDROPHILIC CONTAINING PHOSPHATE GROUP DEHYDRATED PARTIALLY CLEANED BONE REPLACEMENT MATERIAL
Ciobanu et al. The effect of vitamins to hydroxyapatite growth on porous polyurethane substrate
Stępniewski et al. Chitosan and its composites: Properties for use in bone substitution
CN110267688B (en) Bone regeneration material
EP1477191A1 (en) Composite biomaterial containing phospholine
PL449564A1 (en) Macroporous bone implant based on calcium-magnesium zeolite CaMg-Xs functionalized with chitosan and method of its production
CN106267363B (en) A kind of artifical bone
US8465582B2 (en) Process for producing inorganic interconnected 3D open cell bone substitutes
CN103920193A (en) Preparation method of bioactive factor loaded bone-like ceramic composite material
PL449567A1 (en) Macroporous bone implant based on a pH-sensitive zeolite-chitosan-bisphosphonate complex and a method of producing the same
PL449568A1 (en) Macroporous bone implant based on a chitosan-functionalized Na-X zeolite and a method for its production
JPH03196834A (en) Polyasaccharide-ceramic composite gel and its production
Birgani et al. 1.19 Calcium phosphate ceramics with inorganic additives☆
Jungbluth et al. The progress of early phase bone healing using porous granules produced from calcium phosphate cement
Vrânceanu et al. Development and characterization of novel porous collagen based biocomposite for bone tissue regeneration
Yang Progress of bioceramic and bioglass bone scaffolds for load-bearing applications